Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials

Published:2018-06-29 Issue:10 Volume:20 Page:1612-1620
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Romero Jorge¹,Cerrud-Rodriguez Roberto C¹,Diaz Juan Carlos¹,Michaud Gregory F²,Taveras Jose¹,Alviz Isabella¹,Grupposo Vito¹,Cerna Luis¹,Avendano Ricardo¹,Kumar Saurabh³,Kirchhof Paulus⁴,Natale Andrea⁵,Di Biase Luigi¹

Affiliation:

1. Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, 2814 Middletown Rd, Bronx, NY, USA

2. Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN, USA

3. Department of Cardiology, Westmead Hospital, University of Sydney, Darcy Rd, Westmead NSW, Australia

4. The Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, UK

5. Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, TX, USA

Funder

Medtronic

Pfizer

Boston Scientific

Abbott

Biotronik

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/20/10/1612/26003232/euy133.pdf

Reference22 articles.

1. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio;Di Biase;Circulation,2010

2. Clinical benefit of minimally-interrupted dabigatran versus uninterrupted warfarin for catheter ablation of atrial fibrillation: a prospective randomized multicenter trial (ABRIDGE-J);Nogami,2017

3. Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation;Haines;J Interv Card Electrophysiol,2013

4. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter;Kaiser;J Interv Card Electrophysiol,2013

5. Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry;Lakkireddy;. J Am Coll Cardiol,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation;Heart Rhythm;2024-09

2. Italian Registry in the Setting of Atrial Fibrillation Ablation with Rivaroxaban - IRIS;Minerva Cardiology and Angiology;2024-05

3. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation;Journal of Interventional Cardiac Electrophysiology;2024-04-13

4. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation;Europace;2024-03-30

5. Safety and efficacy of catheter ablation of atrial fibrillation in the very elderly (≥80 years old): Insights from the UC San Diego AF Ablation Registry;Clinical Cardiology;2023-08-25